Insider Transactions in Q3 2025 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
8,526
-4.81%
|
$0
$0.29 P/Share
|
|
Jul 01
2025
|
Robert Renninger SVP, Finance and Accounting |
SELL
Open market or private sale
|
Direct |
2,897
-2.58%
|
$0
$0.29 P/Share
|
|
Jul 01
2025
|
Mark Worthington General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
8,526
-7.08%
|
$0
$0.29 P/Share
|
|
Jul 01
2025
|
Martin Javier San CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,842
-13.14%
|
$0
$0.29 P/Share
|
|
Jul 01
2025
|
Mark James Litton President and CEO |
SELL
Open market or private sale
|
Direct |
25,123
-7.16%
|
$0
$0.29 P/Share
|